s:1448:"Myomas are the most common benign tumors of the genital organs in women of childbearing age, causing significant morbidity and impairing their quality of life. In our investigation, we have reviewed the epidemiological data related to the development of myomas in order to homogenize the current data. Therefore, a MEDLINE and PubMed search, for the years 1990-2013, was conducted using a ...

BACKGROUND Uterine fibroids are the most common benign tumor in women, and surgical intervention is still the main fibroid treatment. Patient demands have encouraged development of less-invasive methods such as high-intensity focused ultrasound (HIFU). This study aimed to evaluate the safety and effectiveness of magnetic resonance-guided high-intensity focused ultrasound therapy using a volumet...

Uterine leiomyomas are the most common solid pelvic tumor, occurring in 20% of women over age 35. Most are asymptomatic and can be followed with vaginal ultrasound to rule out ovarian neoplasms and rapid increases in fibroid size. Thus, surgery can usually be avoided. Hypermenorrhea is the major symptom in women with uterine leiomyomas who seek treatment. Other complaints include infertility an...

Background: This case involved a 35-year-old G6P0 with multiple uterine fibroids detected at 12 weeks gestation. Fibroid growth was monitored throughout pregnancy, and intrauterine growth restriction (< 5th centile) was detected at 20 weeks. Fetal demise occurred at 22+ weeks gestation at which time the largest of fibroids measured 150 × 100 × 118 mm and labour was induced. Materials and method...

Uterine fibroids are most common benign uterine neoplasm occurring in 20-30% of reproductive age. Generally, the sonographic appearance leiomyomas is characteristic; however, they can undergo various kind degenerations that dramatically change their and make diagnosis quite challenging. We hereby describe a case report 31-year-old women who presented with menorrhagia dysmenorrhoea her imaging a...

Uterine fibroids also known as Leiomyomas are the non-cancerous growths of uterus. one leading concerns for women in childbearing age. The prevalence is maximum between 35 to 45 years may be symptomatic and asymptomatic sometimes. One every five reproductive age suffers from uterine fibroid. can a single growth or multiple growths. exact cause unknown, however family history, being overweight, ...

Uterine fibroids (leiomyomas or myomas), benign monoclonal tumors, are the most common benign tumors in women. Heavy or prolonged menstrual bleeding, abnormal uterine bleeding, resultant anemia, pelvic pain, infertility, and/or recurrent pregnancy loss are generally associated with uterine fibroids. Although curative treatment of this tumor relies on surgical therapies, medical treatments are c...

Background/introduction In managing women with large uterine fibroids, GnRH agonists can be used to reduce fibroid volume and decrease vascularity to enhance treatment outcomes with MRgFUS. GnRH agonists have been shown to reduce fibroid volume by as much as 30-40%. The purpose of this study was to examine the responsiveness of fibroids to pre-treatment with a GnRH agonist in relation to their ...

INTRODUCTION AND OBJECTIVE Uterine artery embolization (UAE) is a minimally invasive treatment option for symptomatic fibroids. Long-term follow-up studies have shown that at five-year follow-up after UAE, up to 30% of patients required a hysterectomy. Therefore, it seems of utmost importance to identify patients, who are unlikely to benefit from UAE. It has been postulated that the percentage ...